Dangerous potentials in medicamentous prophylaxis of thrombosis - Low molecular-weight heparins versus standard heparins;Gefahrenpotentiale in der medikamentosen thromboseprophylaxe - Niedermolekulare heparine versus standardheparin

Zeitschrift fur Orthopadie und Ihre Grenzgebiete

Volumn 137, Issue 5, 1999, Pages 457-461

  Ganzer, D ^a   Gutezeit, A ^b   Mayer, G ^b  

^a Klin und Poliklin fur Orthopadie   (Germany)

^b NONE

Author keywords

Heparin; Heparin induced thrombocytopenia (HIT) type II; LMWH; Thromboembolism prophylaxis; Thrombosis; UFH

Indexed keywords

ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; FEMALE; HIGH RISK PATIENT; HUMAN; KNEE ARTHROPLASTY; MAJOR CLINICAL STUDY; MALE; ORTHOPEDIC SURGERY; PHLEBOGRAPHY; SURGICAL PATIENT; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOEMBOLISM; TOTAL HIP PROSTHESIS; BLOOD; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DRUG EFFECT; HIP ARTHROPLASTY; MIDDLE AGED; POSTOPERATIVE COMPLICATION; PROSPECTIVE STUDY; REOPERATION; RISK FACTOR; THROMBOCYTE ACTIVATION;

ADULT; AGED; AGED, 80 AND OVER; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; FEMALE; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; MALE; MIDDLE AGED; PLATELET ACTIVATION; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; REOPERATION; RISK FACTORS; THROMBOCYTOPENIA; THROMBOEMBOLISM;

EID: 0033193875     PISSN: 00443220     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1037391     Document Type: Article

References (31)

1. 1 Amiral, J., M. Wolf, A. M. Fischer, C. Boyer-Neumann, A. M. Vissac, D. Meyer: Pathogenicity of IgA and/or IgM antibodies to heparin-PF4 complexes in patients with heparin-induced thrombocytopenia. Brit. J. Haematol. 92 (1996) 954-959
2. 2 Anderson, G. P.: Insights into heparin-induced thrombocytopenia. Brit. J. Haematol. 80 (1992) 504
3. 3 Aster, R. H.: Heparin-induced thrombocytopenia and thrombosis. N. Engl. J. Med. 332 (1995) 1374-1376
4. 4 Avikainen, V., H. Bonsdorf, E. Partio, P. Kaira, S. Hakkinen, P. Usenius, R. Kaaja: Low Molecular Weight Heparin (Enoxaparin) Compared With Unfractionated Heparin in Prophylaxis of Deep Venous Thrombosis and Pulmonary Embolism in Patients Undergoing Hip Replacement. Ann. Chir. Gyn. 84 (1995) 83-90
5. 5 Cadroy, Y., J. Amiral, H. Raynaud, P. Brunel, A. Mazaleyrat, M. Sauer, P. Sie: Involution of Antibodies Anti-PF4/heparin in a Patient with a History of Heparin-induced Thrombozytopenia Reexposed to Heparin. Thromb. Haemost. 72 (1994) 783
6. 6 Chong, B. H., H. N. Magnani: Orgaran in heparin-induced thrombocytopenia. Haemost. 22 (1992) 85-91
7. 7 Chong, B. H., F. Ismail, J. Cade, A. S. Gallus, S. Gordon, C. N. Chesterman: Heparin-induced thrombocytopenia: studies with a new low molecular weight heparinoid, Org 10172. Blood 73 (1989) 1592-1596
8. 8 Collwell, C. W., T. E. Spiro, A. A. Trowbridge, J. W. G. Stephens, G. A. Gardiner, M. A. Ritter: Efficacy and Safety of Enoxaparin Versus Unfractionated Heparin for Prevention of Deep Venous Thrombosis After Elective Knee Arthroplasty. Clinical Orthopedics and Related Research 321 (1995) 19-27
9. ®). Thromb. Haemost. 77 (1997) 26-31
10. 10 Eriksson, B. I., P. Kälebo, B. Anthmyr, H. Wadenvik, L. Tengborn, B. Riesberg: Prevention of Deep-Vein Thrombosis and Pulmonary Embolism After Total Hip Replacement. JBJS 73-A (1991) 484-493
11. 11 Eriksson, B. I., P. W. Jorgensen, P. Kälebo, P. Mouret, N. Rosencher, P. Bösch, M. Baur, S. Ekman, D. Bach, S. Lindbratt, P. Close: A comparison of recombinant Hirudin with a low-molecular-weight heparin to prevent thrombembolic complications after total hip replacement. N. Engl. J. Med 337 (1997) 1329-1335
12. 12 Ganzer, D., A. Gutezeit, G. Mayer, A. Greinacher, P. Eichler: Thromboembolieprophylaxe als Auslöser thrombembolischer Komplikationen. Z. Orthop. 135 (1997) 543-549
13. 13 Greinacher, A.: Anigen Generation in Heparin-Associated Thrombocytopenia: The Nonimmunologic Type and the Immunologic Type are Closely Linked in Their Pathogenesis. Seminars in Thromb. Haemost. 21 (1995) 106-116
14. 14 Greinacher, A., I. Michels, C. Mueller-Eckhardt: Heparin-associated thrombocytopenia: the antibody is not heparin specific. Thromb. Haemost. 67 (1992) 545-549
15. 15 Greinacher, A., C. Mueller-Eckhardt: Heparin-associated thrombocytopenia: no association of immune response with HLA. Vox Sang 65 (1993) 151-153
16. 16 Greinacher, A, I. Michels, V. Kiefel, C. Mueller-Eckhardt: A rapid and sensitive test for diagnosing heparin-associated thrombozytopenia. Thromb. Haemost.66 (1991) 734-736
17. 17 Greinacher, A., C. Mueller-Eckhardt: Diagnostik der Heparin-assoziierten Thrombozytopenie. Dtsch. Med. Wochenschr.116 (1991) 1479-1482
18. 18 Haas, S.: Pråvention, Diagnostik und Therapie von Thrombosen in der Orthopädie und Unfallchirurgie. Orthopäde 26 (1997) 1062-1074
19. 19 Horbach, T., H. Wolf, H. C. Michaelis, W. Wagner, A. Hoffmann, A. Schmidt, H. Beck: A Fixed-Dose Combination of Low Molecular Weight Heparin with Dihydroergotamine versus adjusted-Dose Unfractionated Heparin in the Prevention of Deep-Vein Thrombosis after Total Hip Replacement. Thromb. Haemost. 75 (1996) 246-250
20. 20 Horsewood, P., Th. E. Warkentin, C. P. M. Hayward, J. G. Kelton: The epitope specifity of heparin-induced thrombocytopenia. Brit. J. Haematol. 95 (1996) 161-167
21. 21 King, D. J., D. Sheridan, A. Santos, J. Smith: Heparin-induced Thrombocytopenia: Laboratory studies. Blood 72 (1988) 925-930
22. 22 Köninger, J., A. Greinacher, W. Müller-Beißenhirtz, H. Strosche: Heparin-assoziierte Thrombozytopenie durch niedermolekulare Heparine. Unfallchirurg 98 (1995) 49-51
23. 23 Partsch, H., W. Blättler: Leitlinien zur Thromboseprophylaxe. Phlebol. 25 (1996) 261-266
24. 24 Pauschert, R., C. Diehm, F. Stammler: Leitlinien zur Thromboseprophylaxe in der Orthopädie. Z. Orthop. 5 (1998) 471-479
25. 25 Planes, A., N. Vochelle, J. Y. Darmon, M. Fagola, M. Belland, Y. Huet: Risk of deep-venous thrombosis after hospital discharge in patients having undergone total hip replacement: double-blind randomised comparison of enoxaparin versus placebo. Lanet 27 (1996) 224-228
26. 26 Reininger, C. B., A. J. Reininger, B. Steckmeier, R. Laser, A. Schweiberer, A. Greinacher: Platelet hypersensitivity to heparin an increased incidence of heparin-induced thrombocytopenia (HIT) in leg artherosclerosis. Ann.Haematol.70 (1995) Suppl I A51
27. 27 Samama, M., J. C. Valdes, J. Natali: Forensic medical implications of anticoagulant treatments. J. Mal. Vasc. 21 (1996) 250-255
28. 28 Turpie, A. G. G.: Low-Molecular-weight Heparin: From the Bench to the Orthopedic Patient. Orthopedics 5 Suppl. (1997) 10-13
29. 29 Warkentin, T. E., M. N. Levine, J. Jirsh, P. Horsewood, R. S. Roberts, M. Tech, M. Gent, J. G. Kelton: Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N. Engl. J. Med. 332 (1995) 1330-1335
30. 30 Warkentin, T. E.: Heparin-induced thrombocytopenia. Pathogenesis, frequency, avoidance and management. Drug. Saf. 17 (1997) 325-341
31. 31 Zimlich, R. H., B. M. Fulbright, R. J. Friedman: Current Status of Anticoagulation Therapy After Total Hip and Total Knee Arthroplasty. J. Amer. Acad. Orthop. Surg. 4 (1996) 54-62